SCHEMBL6447443

SCHEMBL6447443

Cc1ccc(S(=O)(=O)ON2CCC(NC(N)=O)(c3ccccc3)CC2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.45
CYP2C19 P33261 2/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HTT P42858 2/20 0.40
VDR P11473 1/20 0.40
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
KDM4E B2RXH2 1/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CYP1A2 P05177 1/20 0.39
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
TACR3 P29371 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7683426 0.92 POLB (0.46) POLBHDAC3HDAC1HDAC2HDAC6
SCHEMBL7744607 0.90 POLB (0.57) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL7750046 0.89 POLB (0.45) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL7679125 0.87 POLB (0.43) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL8368905 0.86 KMT2A (0.43) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL8367979 0.85 HTT (0.47) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL8368924 0.85 ENPP3 (0.46) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL6470098 0.84 POLB (0.46) POLBCYP2C19HDAC3HDAC1HDAC2
SCHEMBL8368908 0.83 ADORA3 (0.47) POLBCYP2C19ALDH1A1MEN1KMT2A
SCHEMBL7749117 0.83 ALDH1A1 (0.51) POLBCYP2C19HDAC3HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP claimed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO claimed
EP-1517708-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS Pfizer Products Inc. (US) 2005-03-30 EP disclosed
WO-2004000355-A1 COMBINATION TREATMENT FOR DEPRESSION AND ANXIETY BY NK1 AND NK3 ANTAGONISTS PFIZER PRODUCTS INC. (US) 2003-12-31 WO disclosed